Patents by Inventor Alfred Stutz

Alfred Stutz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240174678
    Abstract: Provided herein are processes for the preparation of compounds useful in the treatment of cancer.
    Type: Application
    Filed: December 5, 2023
    Publication date: May 30, 2024
    Applicants: Hoffmann-La Roche Inc., Genentech, Inc.
    Inventors: HAIMING ZHANG, JIE XU, GEORG WUITSCHIK, REMY ANGELAUD, SEBASTIAN HEROLD, ALFRED STUTZ, TOBIAS BRUETSCH, JOHANNES BURKHARD
  • Publication number: 20240166595
    Abstract: Methods of making benzoxazepin oxazolidinone compounds as well as synthetic intermediates are described, including compound (10-2) and compound 18:
    Type: Application
    Filed: November 27, 2023
    Publication date: May 23, 2024
    Applicant: Genentech, Inc.
    Inventors: Rémy Angelaud, Tobias Bruetsch, Francis Gosselin, Chong Han, Alfred Stutz
  • Patent number: 11873305
    Abstract: Provided herein are processes for the preparation of indolyl intermediates using Wenker Synthesis for the total synthesis of SERD compounds useful in the treatment of cancer.
    Type: Grant
    Filed: June 28, 2021
    Date of Patent: January 16, 2024
    Assignees: Genentech, Inc., Hoffmann-La Roche Inc.
    Inventors: Haiming Zhang, Jie Xu, Georg Wuitschik, Remy Angelaud, Sebastian Herold, Alfred Stutz, Tobias Bruetsch, Johannes Burkhard
  • Publication number: 20220002304
    Abstract: Provided herein are processes for the preparation of compounds useful in the treatment of cancer.
    Type: Application
    Filed: June 28, 2021
    Publication date: January 6, 2022
    Applicants: Genentech, Inc., Hoffmann-La Roche Inc.
    Inventors: HAIMING ZHANG, JIE XU, GEORG WUITSCHIK, REMY ANGELAUD, SEBASTIAN HEROLD, ALFRED STUTZ, TOBIAS BRUETSCH, JOHANNES BURKHARD
  • Patent number: 10562834
    Abstract: A process to prepare a compound of Formula (I) wherein R3, R4 and R5 are each selected independently from hydrogen, halogen, alkyl, alkenyl, alkynyl, alkoxyl, and wherein the alkyl, alkenyl, alkynyl, and alkoxyl may be optionally substituted with one or more halogen, alkyl, alkenyl, alkynyl, and alkoxyl.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: February 18, 2020
    Assignee: Intervet Inc.
    Inventors: Michael Berger, Stephan Veit, Hans Peter Niedermann, Tobias Kappesser, Alfred Stutz
  • Publication number: 20190135725
    Abstract: A process to prepare a compound of Formula (I) wherein R3, R4 and R5 are each selected independently from hydrogen, halogen, alkyl, alkenyl, alkynyl, alkoxyl, and wherein the alkyl, alkenyl, alkynyl, and alkoxyl may be optionally substituted with one or more halogen, alkyl, alkenyl, alkynyl, and alkoxyl.
    Type: Application
    Filed: January 4, 2019
    Publication date: May 9, 2019
    Applicant: Intervet Inc.
    Inventors: Michael Berger, Stephan Veit, Hans Peter Niedermann, Tobias Kappesser, Alfred Stutz
  • Publication number: 20170121265
    Abstract: A process to prepare a compound of Formula (I) wherein R3, R4 and R5 are each selected independently from hydrogen, halogen, alkyl, alkenyl, alkynyl, alkoxyl, and wherein the alkyl, alkenyl, alkynyl, and alkoxyl may be optionally substituted with one or more halogen, alkyl, alkenyl, alkynyl, and alkoxyl.
    Type: Application
    Filed: May 20, 2015
    Publication date: May 4, 2017
    Applicant: Intervet Inc.
    Inventors: Michael Berger, Stephan Veit, Hans Peter Niedermann, Tobias Kappesser, Alfred Stutz
  • Patent number: 9212136
    Abstract: The present invention is directed to novel processes for the preparation of paricalcitol to novel intermediates used in these processes, and to processes for preparation of the novel intermediates.
    Type: Grant
    Filed: July 22, 2009
    Date of Patent: December 15, 2015
    Assignees: AZAD PHARMACEUTICALS INGREDIENTS AG, UNIVERSITAT ZURICH
    Inventors: Thomas Bader, Alfred Stutz, Hans-Ulrich Bichsel, Changchun Fu
  • Patent number: 8522398
    Abstract: The carriage, which serves for holding a slidable separation element, comprises a carriage body and at least one running wheel, which is a rolling along a rail when the separation elements is displaced.
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: September 3, 2013
    Assignee: Hawa AG
    Inventors: Gregor Haab, Martin Frei, Alfred Stutz
  • Patent number: 8336972
    Abstract: The displacement device serves to hold a separation element, which is pivotally connected to a bracket, which is held slideably by a first beam of a scissor assembly and firmly by a second beam of the scissor assembly with a scissor assembly bearing. The scissor assembly bearing comprises a profile body that is adapted to the bracket and can be connected thereto, which profile body comprises a profile part which is connected articulated to the first end element of an adjusting lever, of which the second end element is connected on the one hand pivotally with the second beam and on the other hand is held by an adjusting bolt, of which the threaded shank is rotatably mounted in a threaded channel of the profile body.
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: December 25, 2012
    Assignee: Hawa AG
    Inventors: Gregor Haab, Martin Frei, Alfred Stutz, Rolf Heisig, Wladyslaw Wasilewski
  • Patent number: 8318936
    Abstract: Process for the preparation of N-methylnaltrexone bromide, wherein a compound of the general formula (I): wherein X? represents an anion other than the bromide anion, and R represents hydrogen or a leaving group, is dissolved or dispersed in a suitable polar solvent, the solution or dispersion is mixed with a compound containing bromide anions, and the resulting reaction mixture is stirred until N-methylnaltrexone bromide has formed and crystallized, wherein, in the case where R represents a leaving group, that group is removed during or after the reaction.
    Type: Grant
    Filed: May 14, 2008
    Date of Patent: November 27, 2012
    Assignee: Cilag AG
    Inventors: Ulrich Weigl, Pascal Schär, Alfred Stutz
  • Publication number: 20110184199
    Abstract: The present invention is directed to novel processes for the preparation of paricalcitol to novel intermediates used in these processes, and to processes for preparation of the novel intermediates.
    Type: Application
    Filed: July 22, 2009
    Publication date: July 28, 2011
    Inventors: Thomas Bader, Alfred Stutz, Hans-Ulrich Bichsel, Changchun Fu
  • Publication number: 20100269291
    Abstract: The carriage, which serves for holding a slidable separation element, comprises a carriage body and at least one running wheel, which is a rolling along a rail when the separation elements is displaced.
    Type: Application
    Filed: April 28, 2010
    Publication date: October 28, 2010
    Applicant: HAWA AG
    Inventors: Gregor Haab, Martin Frei, Alfred Stutz
  • Publication number: 20100270898
    Abstract: The displacement device serves to hold a separation element, which is pivotally connected to a bracket, which is held slideably by a first beam of a scissor assembly and firmly by a second beam of the scissor assembly with a scissor assembly bearing. The scissor assembly bearing comprises a profile body that is adapted to the bracket and can be connected thereto, which profile body comprises a profile part which is connected articulated to the first end element of an adjusting lever, of which the second end element is connected on the one hand pivotally with the second beam and on the other hand is held by an adjusting bolt, of which the threaded shank is rotatably mounted in a threaded channel of the profile body.
    Type: Application
    Filed: April 28, 2010
    Publication date: October 28, 2010
    Applicant: HAWA AG
    Inventors: Gregor Haab, Martin Frei, Alfred Stutz, Rolf Heisig, Wladyslaw Wasilewski
  • Publication number: 20100168427
    Abstract: Process for the preparation of N-methylnaltrexone bromide, wherein a compound of the general formula (I): wherein X? represents an anion other than the bromide anion, and R represents hydrogen or a leaving group, is dissolved or dispersed in a suitable polar solvent, the solution or dispersion is mixed with a compound containing bromide anions, and the resulting reaction mixture is stirred until N-methylnaltrexone bromide has formed and crystallised, wherein, in the case where R represents a leaving group, that group is removed during or after the reaction.
    Type: Application
    Filed: May 14, 2008
    Publication date: July 1, 2010
    Applicant: CILAG AG
    Inventors: Ulrich Weigl, Pascal Schär, Alfred Stutz
  • Patent number: 7560575
    Abstract: A process of making racemic [2S*[R*[R*[R*]]]] and [2R*[S*[S*[S*]]]]-(±)?,??-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] of the compound of the formula (I) and its pure [2S*[R*[R*[R*]]]]- and [2R*[S*[S*[S*]]]]-enantiomer compounds and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: December 28, 2005
    Date of Patent: July 14, 2009
    Assignee: Acino Pharma AG
    Inventors: Thomas Bader, Alfred Stutz, Harald Hofmeier, Hans-Ulrich Bichsel
  • Publication number: 20090048457
    Abstract: A process of making racemic [2S*[R*[R*[R*]]]] and [2R*[S*[S*[S*]]]]-(±)?,??-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] of the compound of the formula (I) and its pure [2S*[R*[R*[R*]]]]- and [2R*[S*[S*[S*]]]]-enantiomer compounds and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: December 28, 2006
    Publication date: February 19, 2009
    Applicants: CIMEX PHARMA AG, UNIVERSITY OF ZURICH
    Inventors: Thomas Bader, Alfred Stutz, Harald Hofmeier, Hans-Ulrich Bichsel
  • Publication number: 20070149612
    Abstract: A process of making racemic [2S*[R*[R*[R*]]]] and [2R*[S*[S*[S*]]]]-(±)?,??-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] of the compound of the formula (I) and its pure [2S*[R*[R*[R*]]]]- and [2R*[S*[S*[S*]]]]-enantiomer compounds and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: December 28, 2005
    Publication date: June 28, 2007
    Inventors: Thomas Bader, Alfred Stutz, Harald Hofmeier, Hans-Ulrich Bichsel